A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy

Tomasz M. Beer, Charles Ryan, Joshi Alumkal, Christopher W. Ryan, Janine Sun, Kristine M. Eilers

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint Dive into the research topics of 'A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy'. Together they form a unique fingerprint.